Group One Trading’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-120,900
| Closed | -$12.1K | – | 7580 |
|
|
2025
Q4 | $12.1K | Buy |
120,900
+11,400
| +10% | +$7.24K | ﹤0.01% | 6696 |
|
|
2025
Q3 | $66.2K | Buy |
109,500
+87,900
| +407% | +$41.4K | ﹤0.01% | 5727 |
|
|
2025
Q2 | $6.72K | Sell |
21,600
-13,000
| -38% | -$5.03K | ﹤0.01% | 6949 |
|
|
2025
Q1 | $16.9K | Sell |
34,600
-393,500
| -92% | -$232K | ﹤0.01% | 5927 |
|
|
2024
Q4 | $367K | Sell |
428,100
-79,600
| -16% | -$499K | ﹤0.01% | 3426 |
|
|
2024
Q3 | $4.32M | Buy |
507,700
+436,000
| +608% | +$2.57M | 0.01% | 1113 |
|
|
2024
Q2 | $335K | Sell |
71,700
-208,000
| -74% | -$984K | ﹤0.01% | 2934 |
|
|
2024
Q1 | $1.9M | Buy |
279,700
+233,600
| +507% | +$1.05M | 0.01% | 1516 |
|
|
2023
Q4 | $154K | Sell |
46,100
-23,200
| -33% | -$57.7K | ﹤0.01% | 4094 |
|
|
2023
Q3 | $173K | Buy |
+69,300
| New | +$114K | ﹤0.01% | 3927 |
|
|
2023
Q1 | – | Sell |
-3,200
| Closed | -$2.43K | – | 7159 |
|
|
2022
Q4 | $2.43K | Sell |
3,200
-1,000
| -24% | -$791 | ﹤0.01% | 6596 |
|
|
2022
Q3 | $4K | Buy |
4,200
+3,500
| +500% | +$4.2K | ﹤0.01% | 6887 |
|
|
2022
Q2 | $1K | Sell |
700
-200
| -22% | -$327 | ﹤0.01% | 7505 |
|
|
2022
Q1 | $2K | Sell |
900
-1,300
| -59% | -$3.48K | ﹤0.01% | 7701 |
|
|
2021
Q4 | $20K | Buy |
+2,200
| New | +$28.9K | ﹤0.01% | 6975 |
|
|
2021
Q3 | – | Sell |
-600
| Closed | -$12K | – | 8126 |
|
|
2021
Q2 | $12K | Buy |
+600
| New | +$11.4K | ﹤0.01% | 7429 |
|
|
2021
Q1 | – | Sell |
-1,300
| Closed | -$29K | – | 7538 |
|
|
2020
Q4 | $29K | Buy |
+1,300
| New | +$27.1K | ﹤0.01% | 5308 |
|
Group One Trading's APLT Position: Q1 2026 in Review
Group One Trading sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 48,675 shares — an estimated $4.87K sold.
Group One Trading first reported a position in APLT in Q1 2021 and held it in 17 quarters. The position peaked at $1.36M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Group One Trading reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 48,675 Applied Therapeutics shares in Q1 2026, an estimated $4.87K.
- Group One Trading first reported a position in Applied Therapeutics in Q1 2021 and held it in 17 quarters.
- Group One Trading's Applied Therapeutics position peaked at $1.36M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.